Literature DB >> 8780247

Interleukin-4 modulates collagen synthesis by human mesangial cells in a type-specific manner.

Y Nakazato1, H Okada, S Tajima, T Hayashida, Y Kanno, H Suzuki, T Saruta.   

Abstract

Several studies have suggested an involvement of interleukin (IL)-4 in the pathophysiology of glomerulonephritis (GN). To elucidate its possible role in GN, we have investigated the effect of IL-4 on collagen accumulation by human mesangial cells (MC). After incubation with IL-1 alpha and/or IL-4 for 48 h, type I, III, and IV collagens in both soluble and cell-associated forms were identified by Western blotting. IL-1 alpha stimulated type I and IV collagen synthesis, lacking significant effect on type III collagen synthesis. In contrast, IL-4 stimulated type III collagen synthesis without affecting type I and type IV synthesis. Enzyme-linked immunosorbent assay confirmed the dose-dependent effect of IL-4 on collagen type III secretion (2.0-fold at 10 ng/ml). Importantly, IL-1 alpha-stimulated type I and IV collagen synthesis was suppressed by concomitant IL-4 treatment. Northern analysis of type I and III procollagen mRNAs displayed consistent results. These data indicate that IL-4 selectively stimulates type III collagen synthesis but also suppresses IL-1 alpha-stimulated type I and IV collagen synthesis. Therefore IL-4 could potentially contribute to the pathological changes in glomerular diseases in cooperate with other cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780247     DOI: 10.1152/ajprenal.1996.270.3.F447

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Progression of renal disease in interleukin-4 transgenic mice: involvement of transforming growth factor-beta.

Authors:  B M Rüger; Q Hasan; K J Erb; P F Davis
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

2.  Collagenofibrotic Glomerulopathy.

Authors:  Masato Miyake; Kan Katayama; Takashi Ehara; Yoshikazu Sado; Shunpei Nawa; Tomohiro Murata; Yasuhide Mizutani; Kensuke Joh; Masaaki Ito; Kaoru Dohi
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.